Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Short Interest Up 7.1% in March

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 1,500 shares, an increase of 7.1% from the March 15th total of 1,400 shares. Based on an average daily volume of 22,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.1% of the company’s shares are sold short.

Bellevue Life Sciences Acquisition Price Performance

Shares of NASDAQ BLAC opened at $10.69 on Tuesday. Bellevue Life Sciences Acquisition has a 52-week low of $10.11 and a 52-week high of $11.16. The business’s 50 day moving average is $10.64 and its two-hundred day moving average is $10.54.

Institutional Trading of Bellevue Life Sciences Acquisition

A number of large investors have recently modified their holdings of the stock. Periscope Capital Inc. increased its position in shares of Bellevue Life Sciences Acquisition by 2,175.8% during the third quarter. Periscope Capital Inc. now owns 615,652 shares of the company’s stock worth $6,403,000 after acquiring an additional 588,600 shares during the period. AQR Arbitrage LLC grew its stake in shares of Bellevue Life Sciences Acquisition by 349.7% during the third quarter. AQR Arbitrage LLC now owns 449,702 shares of the company’s stock worth $4,677,000 after purchasing an additional 349,702 shares in the last quarter. Polar Asset Management Partners Inc. acquired a new position in shares of Bellevue Life Sciences Acquisition during the first quarter worth $3,636,000. ATW Spac Management LLC acquired a new position in shares of Bellevue Life Sciences Acquisition during the first quarter worth $3,636,000. Finally, Boothbay Fund Management LLC acquired a new position in shares of Bellevue Life Sciences Acquisition during the first quarter worth $3,142,000. Hedge funds and other institutional investors own 55.30% of the company’s stock.

Bellevue Life Sciences Acquisition Company Profile

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp.